Literature DB >> 11149037

Transcatheter arterial embolization for advanced hepatocellular carcinoma resulting in a curative resection: report of two cases.

A Mizoe1, J Yamaguchi, T Azuma, H Fujioka, J Furui, T Kanematsu.   

Abstract

Transcatheter hepatic arterial embolization and lipiodolization have been reported to be effective palliative treatments for patients with unresectable hepatocellular carcinoma. We experienced 2 patients with advanced hepatocellular carcinoma which were initially considered to be unresectable due to the extreme extension of the primary lesions. Therefore, transcatheter hepatic arterial embolization with lipiodolization were selected as the treatments of choice. Thereafter, these tumors markedly decreased in size and, as a result, curative resections could subsequently be performed. The pathological examination of the resected specimens revealed necrosis and hyaline degeneration in the main tumors. Viable tumor cells, however, still remained adjacent to the main tumors. Such evidence indicated the limited efficacy of transcatheter hepatic arterial embolization with lipiodolization and the necessity of performing surgical treatment in combination with transcatheter hepatic arterial embolization with lipiodolization. Based on these findings, transcatheter hepatic arterial embolization with lipiodolization both appear to be a good mode of therapy for advanced hepatocellular carcinoma, and in selected patients, subsequent surgery can also be considered.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11149037

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  6 in total

1.  Successful management of postoperative recurrence of hepatocellular carcinoma with p53 gene therapy combining transcatheter arterial chemoembolization.

Authors:  Yong-Song Guan; Yuan Liu; Long Sun; Xiao Li; Qing He
Journal:  World J Gastroenterol       Date:  2005-06-28       Impact factor: 5.742

2.  p53 gene therapy in combination with transcatheter arterial chemoembolization for HCC: one-year follow-up.

Authors:  Yong-Song Guan; Yuan Liu; Qing He; Xiao Li; Lin Yang; Ying Hu; Zi La
Journal:  World J Gastroenterol       Date:  2011-04-28       Impact factor: 5.742

3.  p53 gene (Gendicine) and embolisation overcame recurrent hepatocellular carcinoma.

Authors:  Y S Guan; Y Liu; X P Zhou; X Li; Q He; L Sun
Journal:  Gut       Date:  2005-05-05       Impact factor: 23.059

4.  High-dose iodized oil transcatheter arterial chemoembolization for patients with large hepatocellular carcinoma.

Authors:  Min-Shan Chen; Jin-Qing Li; Ya-Qi Zhang; Li-Xia Lu; Wei-Zhang Zhang; Yun-Fei Yuan; Yong-Ping Guo; Xiao-Jun Lin; Guo-Hui Li
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

Review 5.  Combined interventional therapies of hepatocellular carcinoma.

Authors:  Jun Qian; Gan-Sheng Feng; Thomas Vogl
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

6.  131I-labeled metuximab combined with chemoembolization for unresectable hepatocellular carcinoma.

Authors:  Qing He; Wu-Sheng Lu; Yang Liu; Yong-Song Guan; An-Ren Kuang
Journal:  World J Gastroenterol       Date:  2013-12-21       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.